Related Experiment Video
Updated: May 16, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Exploring implementation challenges of decentralized clinical trials: A qualitative study of policy stakeholder
Ida Hestbjerg1, Ditte Bonde Stanek1, Ulrik Bak Kirk1,2
1Research Unit for General Practice, Aarhus, Denmark.
Background:
The implementation of decentralized clinical trials (DCTs) has received strong political interest in Denmark. Many policy stakeholders may directly or indirectly influence the implementation at a national strategic level. Diverging interests may drive the implementation process in different directions, which may result in an inefficient and unsustainable process.
Objective:
The purpose of this study is to explore implementation challenges of DCTs by examining stakeholder interests that emerge in their accounts of the advantages and disadvantages of DCTs.
Method:
This qualitative study is based on interviews with 15 participants from 12 institutions comprising patient institutions, healthcare institutions, industry institutions, and political institutions. All interviews were conducted between July and December 2023. Additionally, we included 13 policy documents. Interviews and documents were analysed twice. First, we conducted a data-driven thematic analysis. Second, we performed a second-order analysis informed by paradox theory. We used the concept of paradoxical tensions to understand the contradictions that occurred in the stakeholder accounts.
Results:
To make the implementation of DCTs efficient and sustainable, the interests of stakeholders need to be aligned. However, our study demonstrated that the many different stakeholder interests created a knot of paradoxical tensions, which must first be resolved.
Conclusion:
Policy stakeholders must collaborate to resolve the paradoxical tensions and align their different interests towards a common objective. The responsibility of the practical implementation process needs to be allocated to one stakeholder or a few stakeholders, who can guide the process.
More Related Videos
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

